Mineralys Therapeutics, Inc. ($MLYS)
Filing Information
| Accession Number | 0001672659-26-000008 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 21, 2026 |
| Document Date | Jan 20, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
1,248
Total Value
$19,776.64
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jan 20, 2026 | Exercise/Conversion | 416 | $15.44 | $6,423.04 | 50,853 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 20, 2026 | Sale | 416 | $32.10 | $13,353.60 | 50,437 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Jan 20, 2026 | Exercise/Conversion | 416 | $0.00 | $0.00 | 5,834 | Direct | โ | View Details |